JRCT ID: jRCTs052200157
Registered date:17/03/2021
Exploratory research on Anti-SARS-CoV-2 testing
Basic Information
| Recruitment status | Complete |
|---|---|
| Health condition(s) or Problem(s) studied | COVID-19 patients |
| Date of first enrollment | 17/03/2021 |
| Target sample size | 20 |
| Countries of recruitment | |
| Study type | Interventional |
| Intervention(s) | Blood collection |
Outcome(s)
| Primary Outcome | Correlation of SARS-CoV-2 titer between whole blood obtained by novel blood collecting device and matched serum. |
|---|---|
| Secondary Outcome |
Key inclusion & exclusion criteria
| Age minimum | >= 20age old |
|---|---|
| Age maximum | Not applicable |
| Gender | Both |
| Include criteria | COVID-19 patients confirmed by nucleic amplification testing Those who were vaccinated with COVID-19 vaccine at least 2 weeks ago |
| Exclude criteria | N/A |
Related Information
| Primary Sponsor | Nagao Miki |
|---|---|
| Secondary Sponsor | |
| Source(s) of Monetary Support | Drawbridge Health Inc,Roche Diagnostics |
| Secondary ID(s) |
Contact
| Public contact | |
| Name | Miki Nagao |
| Address | Shogoinkawahara-cho, Sakyo-ku Kyoto Japan 606-8507 |
| Telephone | +81-757513502 |
| mnagao@kuhp.kyoto-u.ac.jp | |
| Affiliation | Kyoto University Graduate School of Medicine |
| Scientific contact | |
| Name | Miki Nagao |
| Address | Shogoinkawahara-cho, Sakyo-ku Kyoto Japan 6068507 |
| Telephone | +81-757514967 |
| mnagao@kuhp.kyoto-u.ac.jp | |
| Affiliation | Kyoto University Graduate School of Medicine |